The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
O
|
Omega Healthcare Investors, Inc
LSE:0KBL
|
US |
|
T
|
Tenet Healthcare Corp
F:THC1
|
US |
|
P
|
Pliant Therapeutics Inc
F:9PT
|
US |
|
N
|
Nike Inc
XMUN:NKE
|
US |
|
SD Standard ETC PLC
F:S1P
|
CY |
|
M
|
MTN Group Ltd
SWB:LL6
|
ZA |
|
A
|
Anchun International Holdings Ltd
SGX:BTX
|
CN |
|
E
|
Enbridge Inc
XHAM:EN3
|
CA |
|
S
|
Swiss Re AG
XHAM:SR9
|
CH |
|
H
|
HSBC Holdings PLC
F:HBC2
|
UK |
|
Komatsu Ltd
F:KOM1
|
JP |
|
Allied Telesis Holdings KK
TSE:6835
|
JP |
|
A
|
Advtech Ltd
JSE:ADH
|
ZA |
|
MTAR Technologies Ltd
BSE:543270
|
IN |
|
X
|
XPO Inc
F:UX2A
|
US |
|
O
|
O'Reilly Automotive Inc
F:OM6
|
US |
|
Medalist Diversified, Inc
NASDAQ:MDRR
|
US |
|
Bukit Uluwatu Villa Tbk PT
IDX:BUVA
|
ID |
|
D
|
Denso Corp
F:DNO
|
JP |
|
T
|
Top Energy Company Ltd Shanxi
SSE:600780
|
CN |
|
Tata Consultancy Services Ltd
NSE:TCS
|
IN |
|
G
|
GE Healthcare Technologies Inc
F:L0T
|
US |
|
E
|
EOG Resources Inc
XMUN:EO5
|
US |
|
M
|
MGIC Investment Corp
SWB:MGC
|
US |
Omega Healthcare Investors, Inc (0KBL)’s 12-month stock price forecast through October 2027 has a consensus target of $52.6306, implying 16% upside. The forecast is based on price targets from 19 Wall Street analysts.
Past growth per year Not enough data
Average annual growth cannot be calculated for these periods.
Explore analyst estimates, growth and forecast ranges.
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
According to Wall Street analysts, the average 1-year price target for
0KBL is 52.6306 USD with a low forecast of 46.549 USD and a high forecast of 64.1726 USD.
Over the last 13 years, the compound annual growth rate for Revenue has been 10%. The projected CAGR for the next 3 years is 6%.
Over the last 13 years, the compound annual growth rate for Operating Income has been 10%. The projected CAGR for the next 3 years is 8%.
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 13%. The projected CAGR for the next 3 years is 7%.
Over the last 13 years, the compound annual growth rate for Net Income has been 13%. The projected CAGR for the next 3 years is 5%.
AI-generated answers can contain mistakes, outdated facts, or incomplete information. Always verify important details before making decisions.
The AI Assistant is designed for research and education. It does not provide personalized investment, legal, or tax advice.
We rebuilt our DCF valuation models from the ground up and upgraded how Intrinsic Value is calculated. Alpha Spread now selects the method that best fits each company.
You can now see how the new methodology performed across thousands of stocks on our new Valuation Backtest page. We update the results at the end of every month.
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
Stock intrinsic value is the real worth of a company's stock, based on its financial health and performance.
Instead of looking at the stock's current market price, which can change due to people's opinions and emotions, intrinsic value helps us understand if a stock is truly a good deal or not.
By focusing on the company's actual financial strength, like its earnings and debts, we can make better decisions about which stocks to buy and when.
Read more